IGF1 and Miyoshi myopathy: Additionally, insulin-like growth factor 1 (IGF-1) has been implicated in MM pathogenesis with its role of stimulating mitogenesis, promoting myeloma cell survival and secreting vascular endothelial growth factor, which is essential for angiogenesis [48].